United Arab Emirates Mice Model Market (2025-2030)
The United Arab Emirates Mice Model Market was valued at $1256.3 Million in 2025 and projected to reach to $1969 Million by 2030, representing a compound annual growth rate of CAGR 9.4%. The UAE mice model market is positioned for substantial growth, driven by the nation's strategic focus on becoming a global healthcare and research hub.
United Arab Emirates Mice Model Market Trends and Insights
- Model Type encompasses the diverse categories of laboratory mice utilized in preclinical research, drug development, and disease modeling across pharmaceutical and biotechnology sectors.
- The segmentation by Model Type reflects varying applications, genetic backgrounds, and specialized breeding requirements that drive differentiated demand across research institutions globally. Growth in the Model Type segment is propelled by increasing investment in personalized medicine, expansion of genetic research programs, and rising adoption of transgenic and knockout mouse models for target validation.
- Model Type offerings have become increasingly sophisticated, with researchers demanding specialized strains for oncology, neurology, immunology, and metabolic disease studies.
- Between 2025 and 2030, the Model Type segment will benefit from accelerating genomic research initiatives, regulatory requirements for animal model validation, and the growing prevalence of complex disease models that require specific genetic modifications and phenotypic characteristics..
Key Market Statistics
- CAGR (2025-2030) CAGR 9.4%
- Market Size, 2025 ~USD 1256.3 Million
- Forecast, 2030 ~USD 1969 Million
- Country United Arab Emirates
United Arab Emirates Mice Model Market Overview
UAE Research Infrastructure Growth :
The UAE is rapidly expanding its research and development capabilities with significant investments in biomedical facilities, particularly in Dubai and Abu Dhabi, driving demand for advanced mice models in preclinical research.
Pharmaceutical Development Hub :
UAE's emerging pharmaceutical sector and government initiatives to establish drug development centers are creating increased demand for laboratory mice models for toxicology and efficacy testing.
Regional Leadership Position :
The UAE serves as a regional hub for healthcare innovation in the Middle East, with universities and research institutions increasingly adopting standardized mice models for disease research and drug discovery.
Strategic Healthcare Investments :
Government-backed healthcare modernization programs and partnerships with international biotech firms are accelerating the adoption of specialized mice models in UAE research facilities.
United Arab Emirates Mice Model Market Dynamics
- With increasing investments in life sciences infrastructure and regulatory support for preclinical research, demand for laboratory mice models is expected to expand significantly through 2030.
- The market benefits from UAE's strong pharmaceutical sector development and collaborations with international research institutions. Key growth drivers include rising drug development activities, expansion of academic research programs, and government initiatives promoting biomedical innovation.
- The UAE's role as a regional leader in healthcare technology adoption ensures sustained demand for advanced mice models across pharmaceutical companies, contract research organizations, and academic institutions operating in the emirate..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Model Type segment valued at $1,256.3M in 2025, expanding to $1,969.0M by 2030 at 9.4% CAGR
- Model Type diversity is driven by demand for specialized strains in oncology, neurology, immunology, and metabolic research
- Transgenic and knockout Model Type categories are experiencing accelerated adoption for target validation and precision medicine applications
- Model Type market growth is supported by increased genomic research funding and regulatory requirements for preclinical animal model validation
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
United Arab Emirates Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : UAE-based and regional pharmaceutical firms need market data to plan preclinical research investments, optimize mice model sourcing, and align drug development timelines with market availability.
- Contract Research Organizations (CROs) : CROs operating in UAE require detailed market insights to forecast demand for mice model services, plan capacity expansion, and identify growth opportunities in preclinical testing services.
- Academic & Research Institutions : Universities and research centers in UAE need market intelligence to justify research funding, plan laboratory infrastructure investments, and benchmark their mice model procurement strategies.
- Laboratory Animal Suppliers : Mice breeding facilities and laboratory animal suppliers need UAE-specific market data to assess demand trends, plan breeding programs, and develop targeted distribution strategies.
- Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive market analysis to evaluate UAE biomedical sector opportunities, assess portfolio companies, and guide strategic healthcare investments.
Key Companies in the United Arab Emirates Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Size & Growth Trajectory : Access precise valuation data showing UAE mice model market growth from $1,256.3M (2025) to $1,969.0M (2030) at 9.4% CAGR, enabling accurate investment and expansion planning decisions.
- UAE-Specific Research Insights : Gain localized intelligence on pharmaceutical development trends, research infrastructure expansion, and regulatory environment specific to UAE's healthcare sector and research institutions.
- Competitive Landscape Analysis : Understand market dynamics, key players operating in UAE, and competitive positioning within the regional mice model supply chain and research community.
- Strategic Partnership Opportunities : Identify growth opportunities with UAE-based pharmaceutical companies, contract research organizations, and academic institutions driving demand for specialized mice models.
- Regulatory & Market Entry Guidance : Obtain actionable insights on UAE regulatory requirements, market entry strategies, and compliance standards for mice model suppliers and research service providers.
Frequently asked questions
What is included in the Model Type segment of the Mice Model Market?
The Model Type segment encompasses all classifications of laboratory mice used in research, including inbred strains, transgenic models, knockout models, and disease-specific Model Type variants utilized across pharmaceutical development and academic research.
What is the projected growth rate for the Model Type segment?
The Model Type segment is projected to grow at a 9.4% CAGR from 2025 to 2030, increasing from $1,256.3 million to $1,969.0 million.
Which Model Type categories are driving the fastest growth?
Transgenic and knockout Model Type categories are experiencing the fastest growth, driven by increased adoption in precision medicine, target validation, and complex disease modeling applications.
What factors are influencing Model Type market expansion between 2025 and 2030?
Key drivers of Model Type growth include rising genomic research investments, regulatory mandates for preclinical validation, expansion of personalized medicine initiatives, and growing demand for specialized disease-specific Model Type strains.
How does Model Type segmentation impact research outcomes?
Model Type selection directly influences research reproducibility, translational success, and regulatory acceptance; specialized Model Type variants enable more accurate disease modeling and improve the predictive validity of preclinical findings.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report